603222 济民健康
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-4.283-18.190-3.907-3.9892.340
总资产报酬率 ROA (%)-2.187-10.397-2.440-2.5211.341
投入资产回报率 ROIC (%)-2.450-11.738-2.806-2.8991.573

边际利润分析
销售毛利率 (%)36.31731.05037.31542.43146.284
营业利润率 (%)-13.612-30.181-8.196-4.9005.491
息税前利润/营业总收入 (%)-10.417-30.594-6.274-3.3807.738
净利润/营业总收入 (%)-15.023-35.982-7.235-5.5003.120

收益指标分析
经营活动净收益/利润总额(%)76.61652.58794.853-53.970155.293
价值变动净收益/利润总额(%)0.0050.003-2.100-8.39721.832
营业外收支净额/利润总额(%)4.11111.5074.32610.840-7.056

偿债能力分析
流动比率 (X)0.9390.9231.4701.5711.792
速动比率 (X)0.7930.7451.1121.2871.589
资产负债率 (%)46.92943.47435.04933.07034.621
带息债务/全部投入资本 (%)40.01034.88325.56521.94326.959
股东权益/带息债务 (%)137.699169.702272.662337.061265.315
股东权益/负债合计 (%)104.909121.446174.993192.170181.662
利息保障倍数 (X)-2.757-8.714-2.737-1.5972.966

营运能力分析
应收账款周转天数 (天)60.22463.70968.84163.18667.739
存货周转天数 (天)90.942109.147113.82687.90499.025